Enda Monitor Pregnant Pai Patients

---
name: enda-monitor-pregnant-pai-patients
description: Suggests that pregnant patients with primary adrenal insufficiency be monitored for clinical signs of glucocorticoid over- or under-replacement such as normal weight or gain, fatigue, postural hypotension or hypertension, and hyperglycemia, with at least one review each trimester. Use when managing a pregnant patient with PAI to assess glucocorticoid dosing adequacy.
---

# Monitor Pregnant PAI Patients for Glucocorticoid Over- and Under-Replacement

## STEP 1 — Gather Information
Collect maternal weight trends, self-reported fatigue, orthostatic blood pressure measurements (sitting and standing), fasting or random glucose, and review of current glucocorticoid dose and regimen.  
Compile the data to assess for signs of glucocorticoid over- or under-replacement.

## STEP 2 — Rule In / Rule Out
Determine if any of the following are present: abnormal weight trend (excessive gain or loss), new/worsening fatigue, postural hypotension (SBP drop >20 mmHg) or hypertension (SBP >140 mmHg), hyperglycemia (random glucose >140 mg/dL).  
If any sign is present → proceed to Step 3; if none are present → continue routine prenatal care and reassess at the next trimester visit.

## STEP 3 — Classify or Stratify
Classify the pattern: glucocorticoid over‑replacement suggested by weight gain, insomnia, peripheral edema, or hyperglycemia; glucocorticoid under‑replacement suggested by fatigue, weight loss, postural hypotension, hyperpigmentation, or nausea/vomiting.  
Assign to over‑replacement, under‑replacement, or indeterminate category.

## STEP 4 — Decide
If over‑replacement is suspected, consider reducing the glucocorticoid dose by 10‑20 %; if under‑replacement is suspected, consider increasing the dose by 10‑20 %; if indeterminate, maintain the current dose and schedule close clinical review in 2‑4 weeks.  
Document the dose adjustment plan and arrange follow‑up assessment.

## Clinical Guardrails / Mimics / Pitfalls
Symptoms such as fatigue, edema, and hyperglycemia can occur in normal pregnancy; avoid attributing all changes to glucocorticoid dosing without evaluating obstetric causes. Do not rely solely on serum cortisol or ACTH levels due to pregnancy‑induced increases in cortisol‑binding globulin. Ensure hyperglycemia is evaluated for gestational diabetes per standard prenatal care. Avoid abrupt dose changes; titrate gradually and monitor for adrenal crisis or Cushingoid signs.

## Concrete Clinical Example
A 32‑year‑old woman with known PAI at 20 weeks gestation reports increased fatigue and occasional dizziness on standing; weight is stable; random glucose is 92 mg/dL. Orthostatic BP shows a systolic drop of 25 mmHg without edema. Clinical suspicion of glucocorticoid under‑replacement leads to an increase in hydrocortisone from 20 mg to 25 mg daily in divided doses, with reassessment in 2 weeks.

**Source:** Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710